The Latest: Oklahoma judge finds J&J fueled opioid crisis




  • In US
  • 2019-08-26 22:20:47Z
  • By Associated Press

NORMAN, Okla. (AP) - The Latest on Oklahoma's opioids case against Johnson & Johnson (all times local):

5:10 p.m.

An Oklahoma judge has found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis, ordering the consumer products giant to pay $572 million to help address the problem.

Cleveland County Judge Thad Balkman issued the decision Monday in the nation's first state trial against the companies accused of contributing to the widespread use of the highly addictive painkillers.

An attorney for the company and its subsidiaries says they will appeal. Sabrina Strong called the judge's decision "flawed."

Oklahoma argued the company aggressively marketed opioids for years in a way that overstated their effectiveness and underplayed the addiction risk.

Oklahoma previously reached a $270 million settlement with Oxycontin-maker Purdue Pharma and an $85 million deal with Israeli-owned Teva Pharmaceutical Industries Ltd.

Oklahoma's case could shape negotiations to resolve roughly 1,500 other opioid lawsuits consolidated before a federal judge in Ohio .

___

3:10 p.m.

An Oklahoma judge has found Johnson & Johnson and its subsidiaries helped fuel the state's opioid drug crisis and ordered the consumer products giant to pay $572 million to help address the problem.

Cleveland County Judge Thad Balkman issued the decision Monday in the nation's first state trial against the companies accused of contributing to the widespread use of the highly addictive painkillers.

The company is expected to appeal.

Oklahoma argued the company aggressively marketed opioids for years in a way that overstated their effectiveness and underplayed the addiction risk.

Oklahoma previously reached a $270 million settlement with Oxycontin-maker Purdue Pharma and an $85 million deal with Israeli-owned Teva Pharmaceutical Industries Ltd.

Oklahoma's case could shape negotiations to resolve roughly 1,500 other opioid lawsuits consolidated before a federal judge in Ohio .

___

12 a.m.

An Oklahoma judge is expected to rule in the first state case to go to trial accusing an opioid drugmaker of being responsible for the devastating consequences of addiction to powerful painkillers.

Cleveland County District Judge Thad Balkman is scheduled to deliver his judgment in open court at 3 p.m. Monday. The Oklahoma case is at the forefront of a wave of lawsuits against drug companies over the opioid crisis.

Oklahoma Attorney General Mike Hunter has called consumer products giant Johnson & Johnson a "kingpin" company that helped fuel the most devastating public health crisis in the state's history. Company attorneys say they acted responsibly and that the evidence doesn't support the state's claim.

Two other groups of defendants that manufactured opioids reached settlements before the trial started May 28.

COMMENTS

More Related News

2 Oklahoma police officers accused of repeatedly using stun gun against man charged with his murder
2 Oklahoma police officers accused of repeatedly using stun gun against man charged with his murder
  • US
  • 2020-07-04 22:15:37Z

Two Oklahoma police officers have been charged with second-degree murder for allegedly applying multiple electrical shocks from stun guns to the body of a man who died afterward. Wilson Police Department Officers Joshua Taylor and Brandon Dingman reportedly responded to a call around midnight on July 4, 2019, that 28-year-old Jared Lakey was allegedly acting disorderly. The Oklahoma State Bureau of Investigations was requested by the Carter County Sheriff's Office to assist with the investigation.

Man shocked 50 times by a Taser dies - Oklahoma cops face murder charges, officials say
Man shocked 50 times by a Taser dies - Oklahoma cops face murder charges, officials say
  • US
  • 2020-07-03 14:57:46Z

The arrests come a year after the victim was stunned for almost four minutes.

Johnson & Johnson Gets European Approval for Ebola Vaccine
Johnson & Johnson Gets European Approval for Ebola Vaccine

J&J (JNJ) gets approval from the European Commission for Ebola vaccine.

Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses
Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses

Early signs of the shift came Wednesday, when positive data for one of Pfizer Inc's COVID-19 vaccine candidates sent shares of the large U.S. drugmaker up more than 3%. Although the news had little effect on shares of Pfizer's large rivals in the vaccine race, smaller peers Moderna Inc and Inovio Pharmaceuticals Inc, both of which have previously shown promising COVID-19 data of their own, ended down more than 4% and 25%, respectively. For the week so far, shares of bigger players in the vaccine race, such as Johnson & Johnson and Merck , have also outperformed Inovio and Moderna.

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: US